{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/non-alcoholic-fatty-liver-disease-nafld/background-information/risk-factors/","result":{"pageContext":{"chapter":{"id":"c1592142-fe7a-537c-8d46-2d3836ae5625","slug":"risk-factors","fullItemName":"Risk factors","depth":2,"htmlHeader":"<!-- begin field 7ea8fd19-4d8b-4621-af8d-0083b6220f40 --><h2>Risk factors</h2><!-- end field 7ea8fd19-4d8b-4621-af8d-0083b6220f40 -->","summary":"","htmlStringContent":"<!-- begin item ca2f4cd9-135e-401c-a870-f92aa90a2760 --><!-- begin field 3f9d2dfc-aeba-43c2-ad75-df264c092311 --><ul><li><strong>Metabolic risk factors for non-alcoholic fatty liver disease (NAFLD) include features of the metabolic syndrome that indicate increased cardiovascular risk </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/non-alcoholic-fatty-liver-disease-nafld/references/\">Dyson et al, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/non-alcoholic-fatty-liver-disease-nafld/references/\">World Gastroenterology Organisation, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/non-alcoholic-fatty-liver-disease-nafld/references/\">EASL-EASD-EASO, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/non-alcoholic-fatty-liver-disease-nafld/references/\">NICE, 2016</a>]<strong>:</strong><ul><li>Central obesity — body mass index (BMI) greater than 30 kg/m<sup>2 </sup>or increased waist circumference (greater than 94 cm in men or 80 cm in women [in white people]) — see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/obesity/\">Obesity</a> for more information.</li><li>Impaired glucose regulation or type 2 diabetes mellitus — see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/diabetes-type-2/\">Diabetes - type 2</a> for more information.</li><li>Hypertension — see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/hypertension-not-diabetic/\">Hypertension - not diabetic</a> for more information.</li><li>Hyperlipidaemia (hypertriglyceridaemia and/or low high-density lipoprotein [HDL]-cholesterol level) — see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/lipid-modification-cvd-prevention/\">Lipid modification - CVD prevention</a> for more information.</li></ul></li><li><strong>Other possible risk factors for NAFLD include </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/non-alcoholic-fatty-liver-disease-nafld/references/\">Adams et al, 2005</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/non-alcoholic-fatty-liver-disease-nafld/references/\">Chalasani et al, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/non-alcoholic-fatty-liver-disease-nafld/references/\">World Gastroenterology Organisation, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/non-alcoholic-fatty-liver-disease-nafld/references/\">Sattar et al, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/non-alcoholic-fatty-liver-disease-nafld/references/\">World Gastroenterology Organisation, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/non-alcoholic-fatty-liver-disease-nafld/references/\">NICE, 2016</a>]<strong>:</strong><ul><li>Obstructive sleep apnoea syndrome — see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/obstructive-sleep-apnoea-syndrome/\">Obstructive sleep apnoea syndrome</a> for more information.</li><li>Polycystic ovary syndrome — see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/polycystic-ovary-syndrome/\">Polycystic ovary syndrome</a> for more information.</li><li>Hypothyroidism — see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/hypothyroidism/\">Hypothyroidism</a> for more information.</li><li>A family history of NAFLD.</li><li>Ethnicity — higher risk in Hispanic and Asian people, lower risk in black people.</li><li>Nutritional — total parenteral nutrition (TPN) and refeeding syndrome, rapid weight loss, and jejunoileal bypass surgery.</li><li>Drugs — for example nonsteroidal anti-inflammatory drugs, amiodarone, corticosteroids, diltiazem, methotrexate, and tamoxifen.</li><li>Other liver conditions, such as hepatitis C and Wilson's disease. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/hepatitis-c/\">Hepatitis C</a> for more information.</li></ul></li></ul><!-- end field 3f9d2dfc-aeba-43c2-ad75-df264c092311 --><!-- end item ca2f4cd9-135e-401c-a870-f92aa90a2760 -->","topic":{"id":"abeafb29-55b4-564c-a734-190ce99b5488","topicId":"284bcb15-d9e5-4fa5-97c5-b12061b64d8d","topicName":"Non-alcoholic fatty liver disease (NAFLD)","slug":"non-alcoholic-fatty-liver-disease-nafld","lastRevised":"Last revised in October 2016","chapters":[{"id":"d0fc610b-a161-5d27-aff1-910d3e6bd6af","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"748ff87f-6f43-5b88-826b-8a67516fdf5f","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"4a580b3e-3e5e-50fe-bbe8-63c6a475223b","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"cfdf5ea1-068e-544d-a066-a9e0b5007c65","slug":"changes","fullItemName":"Changes"},{"id":"2d1f70a5-e0ca-56d6-af3c-40bcced1ff70","slug":"update","fullItemName":"Update"}]},{"id":"f6da1f95-da2b-55bd-8bd1-82a26c6e49f3","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"2df5bf15-3a0c-550d-b1ae-49c13b980bd2","slug":"goals","fullItemName":"Goals"},{"id":"899d29ba-a633-5852-b88b-1e12f2e583a0","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"98a2b07c-cb2b-5bf6-8758-a1ffcef6d2b8","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"567377f9-5d4b-58d2-961d-c67f47aa67b3","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"20b1d2c6-1aab-5c3c-8560-98f485589680","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"bde5c853-d1bc-5612-b254-6de06cef5bca","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"271f684c-2115-5009-831e-20aa4e06a952","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"9d30a3cc-c4cb-5049-8a58-68e8628c259e","slug":"definition","fullItemName":"Definition"},{"id":"66b72646-5ad1-5d7a-91e0-65e06d4da026","slug":"prevalence","fullItemName":"Prevalence"},{"id":"9a5c1fa8-bae7-517a-beac-7470da445796","slug":"causes","fullItemName":"Causes"},{"id":"c1592142-fe7a-537c-8d46-2d3836ae5625","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"5f220e0c-e0b7-5332-a19d-50b80b98f34e","slug":"complications","fullItemName":"Complications"},{"id":"ad47e9ed-f83a-51bb-874e-85ea1a9756c3","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"2755df5f-b687-58d9-9f7c-96df41230049","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"9faeeb6d-9870-5bd7-bfd4-35cfd840ff5b","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"e0b64459-7125-5764-b029-3c2c2d770254","slug":"assessment","fullItemName":"Assessment"}]},{"id":"df1d3ccc-4b69-5415-bf4d-b81e66c90d85","fullItemName":"Management","slug":"management","subChapters":[{"id":"92480bd7-0484-5fe9-a7bf-d6797adb368e","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"2c7f01d1-e8b6-5b31-8c34-b4e6ecd555e8","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"00b0d6bf-28e1-5673-b966-4dd5bbb035cc","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"e3a16505-5916-56fe-b828-251f23afd363","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"753add0e-0bf6-59e4-b5a7-e46df0904d4c","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"f6942026-4d74-5fbd-bb79-1aae8f3b4576","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"c2dffddc-29cb-5918-ad31-69cdb772fa22","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"47354e90-5f65-5a83-b670-29798add860f","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"c12b3b71-cdfd-532e-a293-8cd38e7b7b1e","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"271f684c-2115-5009-831e-20aa4e06a952","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}